Executive Director Noman Yakoob bought a total of 5,280 shares in three transactions at rates of Rs 88.37, 89.65, and 91.34 (PSYL)
Filed as: Insider Transaction
Summary
Executive Director Noman Yakoob bought a total of 5,280 shares in three transactions at rates of Rs 88.37, 89.65, and 91.34, increasing his cumulative holding to 36,753,416 shares (26.50%).
Read the original filingTransactions disclosed
| Person | Transaction | Shares | Price | Date |
|---|---|---|---|---|
| Noman YakoobExecutive Director | BuyReady market | 2,839 | Rs 88.37 | 15 May 2026 |
| Noman YakoobExecutive Director | BuyReady market | 742 | Rs 89.65 | 19 May 2026 |
| Noman YakoobExecutive Director | BuyReady market | 1,699 | Rs 91.34 | 20 May 2026 |
As disclosed by the company. A purchase or sale by an insider is a fact about that person's holding, not a signal about the share.
Pakistan Synthetics Limited (PSYL) on Nafa
Last price Rs 299.00 · Synthetic & rayon · You can own PSYL shares from your phone.
More PSYL announcements
- Material informationContract with SACMI and BESS Suppliers AnnouncedPakistan Synthetics signs contracts for new manufacturing systems and BESS solutions, enhancing sustainability and operational efficiency by 2027.
- NoticeTransmission of Quarterly Report for the period ended September 30, 2026
- Financial resultFinancial Results for the First Quarter Ended September 30, 2026Pakistan Synthetics Limited reported a revenue of Rs 3.84 billion and a net profit of Rs 187 million for the quarter ended September 30, 2026, showing strong growth compared to the previous year.
- NoticeExtract of Resolutions Approved in Annual General Meeting - October 28, 2026
- NoticeBoard Meeting
- NoticeTransmission of Annual Report for the Year Ended June 30, 2026
Source: Pakistan Synthetics Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.